Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Hemodial Int. 2017 Apr 3;21(Suppl 1):S93–S103. doi: 10.1111/hdi.12558

Table 1.

IV iron formulations available in the United States

Generic Name Brand Name (Manufacturer) Approval Year Test Dose Needed Labeled Dosage for Iron Deficiency IV administration time Notes
High-molecule-weight iron dextran DexFerrum (American Regent) 1954 Yes 1000 mg in 10 divided doses or total dose as a single IV infusion Undiluted at an infusion rate not to exceed 50 mg (1mL)/min Anaphylactic-type reactions and fatalities reported; resuscitation equipment and trained personnel necessary
Low-molecule-weight iron dextran InFed (Watson) 1992 Yes 1000 mg in 10 divided doses or total dose as a single IV infusion Undiluted at an infusion rate not to exceed 50 mg (1mL)/min Anaphylactic-type reactions and fatalities reported; resuscitation equipment and trained personnel necessary
Ferric gluconate Ferrlecit (Sanofi-Aventis); Nulecit (Watson) 1999 No 1000 mg in 8 divided doses (HD only) 60 minutes diluted in saline; undiluted IV push at 12.5 mg/min Reactions to benzyl alcohol ingredient
Iron sucrose Venofer (American Regent) 2000 No 1000 mg in 10 divided doses (HD); 1000 mg in 5 divided doses (NDD); 1000 mg in 2 doses of 300 mg and 1 dose of 400 mg (PD) 2–5 minutes undiluted or 15 minutes if diluted in saline (HD, NDD); 300 mg infused over 1.5 hours, 400 mg over 2.5 hours 14 days later, 400 mg infused over 2.5 hours 14 days later (PD) 7-day stability; anaphylactoid reactions
Ferumoxytol Feraheme (AMAG) 2009 No 510 mg × 2 doses separated by 3 or 8 days IV infusion diluted in saline or Dextrose Injection over 15+ minutes MRI interaction for up to 3 mo; resuscitation equipment and trained personnel necessary. Anaphylactic-type reactions presenting with cardiac/cardiorespiratory arrest, clinically significant hypotension, syncope, and unresponsiveness
Ferric carboxymaltose Injectafer (American Reagent) 2013 No 750 mg × 2 doses separated by at least 7 days (weighing ≥110 lb); 15 mg/kg body weight separated by at Least 7 days (weighing <110 lb) Undiluted IV push at 100 (2mL) per minute, or diluted infusion over at least 15 minutes Anaphylactic-type reactions presenting with shock, clinically significant hypotension, loss of consciousness, and/or collapse

Note: IV= intravenous; HD=hemodialysis; NDD=Non-hemodialysis dependent; PD=peritoneal dialysis